Explore our brands

Our brands bring together the industry's most influential leaders and scientific experts, inspiring thought-provoking and insightful content that offers a unique perspective on R&D trends and challenges.
Contact
Biomarker Discovery & Development | Whitepapers & Reports

Development and Validation of Five Idiopathic Pulmonary Fibrosis (IPF) Biomarker Panels Comprising 12 Immunoassays: Advancing Clinical Diagnostic, Pharmacodynamic and Disease Activity Assessments in IPF

12 March 2024
Open document in a new tab

Related Resources

A New Golden Age for Target Identification: Accessing the Novel Druggable Space with Discovery Proteomics

On-demand webinar presented by Mo Jain, MD, PhD, Founder and CEO, Sapient and Jonathan Usuka, PhD, MBA Chief Business Officer, Sapient
Read More

Explore novel targets and biomarkers in cancer

Read More

IHC-validated carrier-free antibodies to de-risk your multiplexing assays

Read More